BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 15591061)

  • 1. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells.
    Wochnik GM; Rüegg J; Abel GA; Schmidt U; Holsboer F; Rein T
    J Biol Chem; 2005 Feb; 280(6):4609-16. PubMed ID: 15591061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of hsp90-associated immunophilins to cytoplasmic dynein: direct binding and in vivo evidence that the peptidylprolyl isomerase domain is a dynein interaction domain.
    Galigniana MD; Harrell JM; Murphy PJ; Chinkers M; Radanyi C; Renoir JM; Zhang M; Pratt WB
    Biochemistry; 2002 Nov; 41(46):13602-10. PubMed ID: 12427021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor beta and glucocorticoid responsiveness.
    Zhang X; Clark AF; Yorio T
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1037-47. PubMed ID: 18326728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyl-prolyl isomerase activity.
    Erlejman AG; De Leo SA; Mazaira GI; Molinari AM; Camisay MF; Fontana V; Cox MB; Piwien-Pilipuk G; Galigniana MD
    J Biol Chem; 2014 Sep; 289(38):26263-26276. PubMed ID: 25104352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus.
    Galigniana MD; Radanyi C; Renoir JM; Housley PR; Pratt WB
    J Biol Chem; 2001 May; 276(18):14884-9. PubMed ID: 11278753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All of the protein interactions that link steroid receptor.hsp90.immunophilin heterocomplexes to cytoplasmic dynein are common to plant and animal cells.
    Harrell JM; Kurek I; Breiman A; Radanyi C; Renoir JM; Pratt WB; Galigniana MD
    Biochemistry; 2002 Apr; 41(17):5581-7. PubMed ID: 11969419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different regions of the immunophilin FKBP52 determine its association with the glucocorticoid receptor, hsp90, and cytoplasmic dynein.
    Silverstein AM; Galigniana MD; Kanelakis KC; Radanyi C; Renoir JM; Pratt WB
    J Biol Chem; 1999 Dec; 274(52):36980-6. PubMed ID: 10601253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus.
    Galigniana MD; Harrell JM; O'Hagen HM; Ljungman M; Pratt WB
    J Biol Chem; 2004 May; 279(21):22483-9. PubMed ID: 15004035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins.
    Davies TH; Ning YM; Sánchez ER
    J Biol Chem; 2002 Feb; 277(7):4597-600. PubMed ID: 11751894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hsp90-FKBP52 complex links the mineralocorticoid receptor to motor proteins and persists bound to the receptor in early nuclear events.
    Galigniana MD; Erlejman AG; Monte M; Gomez-Sanchez C; Piwien-Pilipuk G
    Mol Cell Biol; 2010 Mar; 30(5):1285-98. PubMed ID: 20038533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophilin-A is bound through its peptidylprolyl isomerase domain to the cytoplasmic dynein motor protein complex.
    Galigniana MD; Morishima Y; Gallay PA; Pratt WB
    J Biol Chem; 2004 Dec; 279(53):55754-9. PubMed ID: 15496417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506.
    Davies TH; Ning YM; Sánchez ER
    Biochemistry; 2005 Feb; 44(6):2030-8. PubMed ID: 15697228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D structure of human FK506-binding protein 52: implications for the assembly of the glucocorticoid receptor/Hsp90/immunophilin heterocomplex.
    Wu B; Li P; Liu Y; Lou Z; Ding Y; Shu C; Ye S; Bartlam M; Shen B; Rao Z
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8348-53. PubMed ID: 15159550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The helix 1-3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones.
    Cluning C; Ward BK; Rea SL; Arulpragasam A; Fuller PJ; Ratajczak T
    Mol Endocrinol; 2013 Jul; 27(7):1020-35. PubMed ID: 23686112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsp90-binding immunophilin FKBP52 modulates telomerase activity by promoting the cytoplasmic retrotransport of hTERT.
    Jeong YY; Her J; Oh SY; Chung IK
    Biochem J; 2016 Oct; 473(20):3517-3532. PubMed ID: 27503910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo.
    Riggs DL; Roberts PJ; Chirillo SC; Cheung-Flynn J; Prapapanich V; Ratajczak T; Gaber R; Picard D; Smith DF
    EMBO J; 2003 Mar; 22(5):1158-67. PubMed ID: 12606580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryo-EM reveals how Hsp90 and FKBP immunophilins co-regulate the glucocorticoid receptor.
    Noddings CM; Johnson JL; Agard DA
    Nat Struct Mol Biol; 2023 Dec; 30(12):1867-1877. PubMed ID: 37945740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52.
    Zgajnar NR; De Leo SA; Lotufo CM; Erlejman AG; Piwien-Pilipuk G; Galigniana MD
    Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30717249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of FKBP51/FKBP52 chimeras and mutants for Hsp90 binding and association with progesterone receptor complexes.
    Barent RL; Nair SC; Carr DC; Ruan Y; Rimerman RA; Fulton J; Zhang Y; Smith DF
    Mol Endocrinol; 1998 Mar; 12(3):342-54. PubMed ID: 9514152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsp90-binding immunophilin FKBP51 forms complexes with hTERT enhancing telomerase activity.
    Lagadari M; Zgajnar NR; Gallo LI; Galigniana MD
    Mol Oncol; 2016 Aug; 10(7):1086-98. PubMed ID: 27233944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.